Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FN1S5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,360
Award facts
- Contract value 100% obligated
- $17,359.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,359.56 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable immunosuppressant medication used to treat autoimmune conditions. Issued on February 2, 2026, with an ultimate completion date of February 3, 2026, this firm fixed-price delivery order represents a non-set-aside competitive award under DLA's pharmaceutical supply chain. The award is structured as a child contract under AmerisourceBergen's parent company, Cencora, Inc., which maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026.
This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical supply relationship with DLA, which enables the company to fulfill diverse medical supply needs across military healthcare systems globally. AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities across multiple therapeutic domains. The firm fixed-price structure and rapid completion timeline reflect the transactional nature of this particular order while demonstrating the company's established capability to support federal military healthcare operations with essential pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FN1S5?
SPE2DR26FN1S5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FN1S5 worth?
The government has obligated $17,360 on SPE2DR26FN1S5.
Is contract SPE2DR26FN1S5 an order under another contract?
Yes. SPE2DR26FN1S5 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1S5 competed?
The extent of competition for SPE2DR26FN1S5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award